Sentynl Therapeutics, Inc.

CA · United States · Reporting entity ID 100000131384

Total reported 2019–2025

$980K

#1,318 of 2,960 reporting companies — 0% of all reported industry payments

$876K in general payments across 4,316 records, plus $104K in research funding across 12 records.

How it breaks down

General payments $875,742

Research funding $104,089

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.